Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71 CHF | +1.28% |
|
-0.42% | +39.49% |
Jun. 18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
Jun. 03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.49% | 1.25B | |
+59.29% | 846B | |
+38.56% | 628B | |
-4.59% | 360B | |
+17.79% | 322B | |
+9.43% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+13.01% | 173B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals N : Names COO, Chief People Officer